1. Home
  2. HRMY vs UFPT Comparison

HRMY vs UFPT Comparison

Compare HRMY & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • UFPT
  • Stock Information
  • Founded
  • HRMY 2017
  • UFPT 1963
  • Country
  • HRMY United States
  • UFPT United States
  • Employees
  • HRMY N/A
  • UFPT N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • UFPT Medical/Dental Instruments
  • Sector
  • HRMY Health Care
  • UFPT Health Care
  • Exchange
  • HRMY Nasdaq
  • UFPT Nasdaq
  • Market Cap
  • HRMY 2.2B
  • UFPT 2.1B
  • IPO Year
  • HRMY 2020
  • UFPT 1993
  • Fundamental
  • Price
  • HRMY $34.56
  • UFPT $254.56
  • Analyst Decision
  • HRMY Strong Buy
  • UFPT Strong Buy
  • Analyst Count
  • HRMY 8
  • UFPT 2
  • Target Price
  • HRMY $54.38
  • UFPT $323.50
  • AVG Volume (30 Days)
  • HRMY 557.4K
  • UFPT 83.8K
  • Earning Date
  • HRMY 02-25-2025
  • UFPT 02-25-2025
  • Dividend Yield
  • HRMY N/A
  • UFPT N/A
  • EPS Growth
  • HRMY N/A
  • UFPT 29.17
  • EPS
  • HRMY 2.11
  • UFPT 6.99
  • Revenue
  • HRMY $681,879,000.00
  • UFPT $461,848,000.00
  • Revenue This Year
  • HRMY $25.11
  • UFPT $27.98
  • Revenue Next Year
  • HRMY $19.19
  • UFPT $18.23
  • P/E Ratio
  • HRMY $16.46
  • UFPT $38.19
  • Revenue Growth
  • HRMY 25.83
  • UFPT 18.48
  • 52 Week Low
  • HRMY $28.14
  • UFPT $188.50
  • 52 Week High
  • HRMY $41.61
  • UFPT $366.41
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 35.54
  • UFPT 44.24
  • Support Level
  • HRMY $37.03
  • UFPT $251.22
  • Resistance Level
  • HRMY $39.91
  • UFPT $289.57
  • Average True Range (ATR)
  • HRMY 1.34
  • UFPT 11.08
  • MACD
  • HRMY -0.58
  • UFPT -1.19
  • Stochastic Oscillator
  • HRMY 9.86
  • UFPT 19.87

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Share on Social Networks: